CoChat

Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine

Open access
Pringle, A, Parsons, E, Cowen, LG, McTavish, SF, Cowen, PJ, Harmer, CJ · 2012 · Journal of Psychopharmacology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

There is growing interest in the role of the glutamatergic system both in depression and as a novel target for treatments. Preclinical studies suggested that the non-competitive N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine might have antidepressant properties, but a randomised controlled trial failed to support this. A healthy volunteer model of emotional processing was used to assess the neuropsychological profile of action of memantine. Healthy volunteers ( n=32) were randomised to receive a single dose of memantine (10 mg) or placebo, and subsequently completed a battery of tasks measuring emotional processing, including facial expression recognition, emotional memory, dot-probe and emotion-potentiated startle tasks, as well as working and verbal memory. Memantine treated volunteers showed an increased emotion-potentiated startle, and a reduced bias for negative items in emotional recognition memory. There were no effects of the drug on any other aspect of emotional or non-emotional information processing. These results suggest that a single dose of memantine produces an early anxiogenic response in the emotion-potentiated startle similar to that seen following a single dose of the selective serotonin reuptake inhibitor, citalopram. However, the overall profile of effects is more limited than that which might be expected in response to a conventional antidepressant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881112446535

Cites

Statistics

Figures

Figure 1. Emotion-potentiated startle. Figure shows the mean z-transformed eye blink response to a burst of loud white noise during pleasant, unpleasant and neutral emotional pictures for placebo (white bars) and drug (grey bars) treated groups. Error bars show standard error. * p<0.001.
Figure 1. Emotion-potentiated startle. Figure shows the mean z-transformed eye blink response to a burst of loud white noise during pleasant, unpleasant and neutral emotional pictures for placebo (white bars) and drug (grey bars) treated groups. Error bars show standard error. * p<0.001.CC BY · PubMed Central
Figure 2. Emotional recognition memory false alarms. Figure shows the mean number of falsely recognised emotionally positive and negative personality characteristic words for placebo (white bars) and drug (grey bars) treated groups. Error bars show standard error.
Figure 2. Emotional recognition memory false alarms. Figure shows the mean number of falsely recognised emotionally positive and negative personality characteristic words for placebo (white bars) and drug (grey bars) treated groups. Error bars show standard error.CC BY · PubMed Central
Figure 3. Emotional dot probe. Figure shows the mean attentional vigilance score (averaged across the masked and unmasked conditions of the task) for the placebo (white bars) and drug (grey bars) treated groups. Attentional vigilance scores were calculated for each participant by subtracting the reaction time from trials when probes appeared in the same position as the emotional word (congruent trials from trials when probes appeared in the opposite position as the emotional word (incongruent trials)). Error bars show standard error.
Figure 3. Emotional dot probe. Figure shows the mean attentional vigilance score (averaged across the masked and unmasked conditions of the task) for the placebo (white bars) and drug (grey bars) treated groups. Attentional vigilance scores were calculated for each participant by subtracting the reaction time from trials when probes appeared in the same position as the emotional word (congruent trials from trials when probes appeared in the opposite position as the emotional word (incongruent trials)). Error bars show standard error.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 53 · Cited by 21

Research works printed but not linked: 6

  1. Feusner JD, 2009, Psychopharmacol Bull, 42, 81
  2. First MB, 1996, Structured Clinical Interview for Axis I and II DSM-IV Disorders: Patient Edition (SCID-IV/P)
  3. Nelson HE, 1982, National Adult Reading Test (NART): Test Manual
  4. Rey A, 1964, L’examen de clinique en psychologie
  5. Skuza G, 2003, Pol J Pharmacol, 55, 1149
  6. Spielberger CD, 1970, STAI Manual

Metadata

Authors
Pringle, A., Parsons, E., Cowen, L., McTavish, S., Cowen, P., & Harmer, C.
Affiliations
  • University of Oxford (GB)
  • Department of Psychiatry, University of Oxford, Oxford, UK
Corresponding author
Pringle, A
Venue
Journal of Psychopharmacology
Published
2012-05-16
Volume
26
Issue
11
Pages
1417-1423
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2115893285
Cited by
21
References
53
Citations by year
2026: 1 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2015: 4 · 2014: 2 · 2013: 2
FWCI
1.88
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Medical Research Council (G0801432, G0801432/1)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
memantine, antidepressant potential, NMDA receptor antagonists, glutamatergic system, depression, anxiogenic effects, emotional memory, facial expression recognition, dot-probe task, working memory, citalopram, healthy volunteers
MeSH terms
Adolescent, Adult, Antidepressive Agents, Double-Blind Method, Emotions, Humans, Male, Memantine, Memory, Short-Term, Neuropsychological Tests, Reflex, Startle, Citalopram, Receptors, N-Methyl-D-Aspartate, Selective Serotonin Reuptake Inhibitors, Excitatory Amino Acid Antagonists, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine. https://app.cochat.ai/papers/10.1177/0269881112446535
The paper
Pringle, A., Parsons, E., Cowen, L., McTavish, S., Cowen, P., & Harmer, C. (2012). Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine. Journal of Psychopharmacology. https://doi.org/10.1177/0269881112446535

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.